BlogDec 2016

Good News about Lung Cancer? Thanks to Bench Science and Pharma

Good News about Lung Cancer? Thanks to Bench Science and Pharma By Kathleen Hoffman, PhD, MSPH Targeted therapies, monoclonal antibodies, and immune checkpoint inhibitors are the good news - making a significant [...]

Launching a New Drug During a Pandemic? Successful Launches Included a Rapid Pivot to Social Media

Launching a New Drug During a Pandemic? Successful Launches Included a Rapid Pivot to Social Media By Paul Nash How has the pandemic affected pharmaceutical product launches? Experts say that social media [...]

By |October 27th, 2020|marketing, Patient Insights|0 Comments

How Has COVID-19 Impacted Patients with Rare Conditions?

How Has COVID-19 Impacted Patients with Rare Conditions? By Judy Chandler Over 600,000 Inspire members are affected by rare conditions. As a vital partner to 40 rare disease non-profit advocacy organizations, Inspire’s [...]

By |October 20th, 2020|Patient Communities, Patient Insights|0 Comments

Patients Are The Best Resource For Defining Study Endpoints

Patients Are The Best Resource For Defining Study Endpoints By Robert Gardner In September, the World Orphan Drug Congress USA Fall Webinar series opened with a program called: “Understanding the Novel Challenges [...]

By |October 6th, 2020|Patient Communities, Patient Insights|0 Comments

For Ovarian Cancer Awareness Month: Teal Sisters Support Each Other and Discuss Treatments on Inspire

For Ovarian Cancer Awareness Month: Teal Sisters Support Each Other and Discuss Treatments on Inspire By Kathleen Hoffman, PhD, MSPH September is Ovarian Cancer Awareness Month. The Ovarian Cancer Research Alliance (OCRA), [...]

Online Health Communities Change Patients’ Journeys: A Live Virtual Roundtable

Online Health Communities Change Patients’ Journeys: A Live Virtual Roundtable By Dana Deighton In the fable of the Ugly Duckling, the duckling feels isolated by his differences until he discovers that he [...]